Endocrine Society Argues for Inclusion of EDCs in EU Chemicals Strategy

In May, the European Commission released a roadmap outlining plans for a Chemicals Strategy for Sustainability. The Chemicals Strategy, which will form a component of the European Green Deal, seeks to “reduce the risks associated with producing and using chemicals” by improving the European Union (EU) regulatory process and strengthening the regulatory framework for harmful chemicals.

The Endocrine Society’s EU Endocrine-Disrupting Chemicals (EDC) Task Force submitted comments to the Roadmap to ensure that the Chemicals Strategy advances our priorities and improves EU regulation of chemicals that interfere with endocrine systems. Our members stressed the need for ambitious legislative measures to address common EDC exposures that are consistent with the latest endocrine science. We also called for the identification of gaps in testing strategies and an accelerated and more coherent identification process for EDCs.

As policy makers develop and revise the Chemicals Strategy and other components of the EU Green Deal, the Endocrine Society will continue to ensure that EDCs are prioritized due to the ongoing harm that they cause to humans and the environment.

For the latest news on EDCs in the EU, we encourage members to check out our new online newsletter on the Endocrine Society’s EDC webpage at endocrine.org/edc.

 

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…